MUC1-KLH vaccine/QS21

BIOLOGICAL3 trials

Sponsors

Memorial Sloan Kettering Cancer Center

Conditions

Breast CancerFallopian Tube CancerOvarian CancerPrimary Peritoneal Cavity CancerProstate Cancer

Phase 1

Vaccine Therapy in Treating Patients With Breast Cancer

CompletedNCT00004156

Memorial Sloan Kettering Cancer CenterBreast Cancer

Start: 1999-05-31Updated: 2013-10-30

Vaccine Therapy in Treating Patients With Ovarian, Fallopian Tube, or Peritoneal Cancer

CompletedNCT00006041

Memorial Sloan Kettering Cancer CenterFallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer

Start: 2000-02-29End: 2002-02-28Updated: 2013-06-19

Vaccine Therapy Plus QS21 in Treating Patients With Prostate Cancer

CompletedNCT00005632

Memorial Sloan Kettering Cancer CenterProstate Cancer

Start: 1999-06-30End: 2009-03-31Updated: 2013-01-31